Biotechnology Archives

June 17, 2026

Elon Musk is betting big on this industry. This stock stands to benefit.

Biotech stocks, humanoid robotics, and global financials are showing remarkable strength. Discover the trends that could drive the market’s next big winners.

Read this issue

May 28, 2026

This bleeding-edge technology has huge upside and poised for a breakout

Solar energy, AI genomics, and biotechnology stocks are gaining momentum as investors chase the next major growth trends in health care and energy.

Read this issue

May 22, 2026

How to profit alongside the Trump family’s digital money bets

Solar energy, Bitcoin, and genomics stocks are gaining momentum. Learn which companies could benefit most from these fast-growing investment trends.

Read this issue

May 11, 2026

We hit a grand slam in semiconductors. How to trade it from here

AI stocks are driving huge gains in semiconductors, biotech, and industrials. Discover the companies and trends leading the next phase of the AI boom.

Read this issue

May 7, 2026

Amgen’s Stock Has Stumbled Despite Strong Earnings. Here’s What Investors Are Watching Right Now

Amgen delivered strong quarterly results, yet its stock has been falling. Explore the key reasons, including clinical setbacks, rising competition, and valuation concerns.

Read this issue

February 17, 2026

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo

Danaher is acquiring Masimo in a $9.9 billion all-cash deal. Here’s what the acquisition means for DHR stock, Masimo’s Apple litigation, and long-term investors.

Read this issue

Biotechnology

Article Date Range

Author

Categories

Elon Musk is betting big on this industry. This stock stands to benefit.

This bleeding-edge technology has huge upside and poised for a breakout

How to profit alongside the Trump family’s digital money bets

We hit a grand slam in semiconductors. How to trade it from here

Amgen’s Stock Has Stumbled Despite Strong Earnings. Here’s What Investors Are Watching Right Now

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo